Canopy Growth (CGC) Return on Capital Employed Growth (3y) (2023 - 2026)
Canopy Growth (CGC) Return on Capital Employed Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1,036.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 175.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 120.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 434.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -295.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1,076.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1,898.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Canopy Growth | 445.49 Mn | 198.48 Mn | 16.08 Mn | 3,301.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,301.00 |
| Dec 31, 2025 | 9,523.00 |
| Sep 30, 2025 | 7,995.00 |
| Jun 30, 2025 | 4,873.00 |
| Dec 31, 2024 | -669.00 |
| Sep 30, 2024 | -823.00 |
| Jun 30, 2024 | -84.00 |
| Mar 31, 2024 | -374.00 |
| Dec 31, 2023 | -2,093.00 |
| Sep 30, 2023 | -1,563.00 |
| Jun 30, 2023 | -2,214.00 |
| Mar 31, 2023 | -9,411.00 |